Mojan Assadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mojan Assadi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Bahram Rashidkhani
Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Esfandiar Asgari
Educational Supervisor Cancer Institute Imam Khomeini Hospital Tehran University of Medical Sciences Tehran Iran
2 shared publications- Saba Jalali
Human Nutrition, Faculty of Land and Food Systems, University of British Columbia, Vancouver, Canada
2 shared publications Shiva Hatami
Department of Microbiology and Immunology
2 shared publications- Alireza Bahrami
Student Research Committee, Department and Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran 4739-19395, Iran
1 shared publication - Alireza Shakib1 shared publication
Latest Publications
- Open Access
- 29 August 2024
- Published by Maad Rayan Publishing Company in International Journal of Enteric Pathogens
- Vol. 12 (3) , 142-145
Bortezomib Administration in a Pregnant Woman Despite its Contraindication: A Case Report
Multiple myeloma (MM) is characterized by the malignant proliferation of monoclonal plasma cells in the bone marrow. Generally, it is a malignancy of older people, and its presentation before the age of 40 is rare. In addition, the incidence of MM during pregnancy is very rare. This case study reports a 38-year-old woman with a 1.5-year history of bone pain and diagnosis of immunoglobulin G and a kappa light-chain myeloma (Durie-Salmon stage IIIA, International Staging System III) and poor cytogenetic prognosis (del 11p, 46XX). The treatment plan included four courses of bortezomib, lenalidomide, and dexamethasone were planned as her treatment. At the end of the third course, it was revealed that she was in the 9th week of pregnancy, but her treatment continued as before because of refusing abortion and changing treatment modality. Despite continuing this treatment, a healthy boy was born without any malformations. Even in the next four-year follow-up, her son had normal growth and development. Regarding the contraindication of bortezomib during pregnancy, some data demonstrated that receiving bortezomib during pregnancy had no teratogenic effects on the fetus. This case study aimed to present this issue as well. Perhaps the declaration of bortezomib contraindication during pregnancy will become less in the future.
- 29 August 2024
- Published by Maad Rayan Publishing Company in International Journal of Enteric Pathogens
- Vol. 12 (3) , 142-145
Open AccessBortezomib Administration in a Pregnant Woman Despite its Contraindication: A Case Report
Multiple myeloma (MM) is characterized by the malignant proliferation of monoclonal plasma cells in the bone marrow. Generally, it is a malignancy of older people, and its presentation before the age of 40 is rare. In addition, the incidence of MM during pregnancy is very rare. This case study reports a 38-year-old woman with a 1.5-year history of bone pain and diagnosis of immunoglobulin G and a kappa light-chain myeloma (Durie-Salmon stage IIIA, International Staging System III) and poor cytogenetic prognosis (del 11p, 46XX). The treatment plan included four courses of bortezomib, lenalidomide, and dexamethasone were planned as her treatment. At the end of the third course, it was revealed that she was in the 9th week of pregnancy, but her treatment continued as before because of refusing abortion and changing treatment modality. Despite continuing this treatment, a healthy boy was born without any malformations. Even in the next four-year follow-up, her son had normal growth and development. Regarding the contraindication of bortezomib during pregnancy, some data demonstrated that receiving bortezomib during pregnancy had no teratogenic effects on the fetus. This case study aimed to present this issue as well. Perhaps the declaration of bortezomib contraindication during pregnancy will become less in the future.
- Open Access
- 21 October 2022
- Published by Brieflands in Modern Care Journal
- Vol. 20 (1)
Facilitating Factors and Barriers to Coping with Body Image Altered in Women with Breast Cancer
Background: Coping with body image alteration is one of the most challenging breast cancer treatments. Identifying the facilitators and barriers is essential for integrative care planning to improve coping with body image in women with breast cancer. Objectives: This study aimed to explore facilitating factors and barriers to coping with body image altered in women with breast cancer. Methods: This study was done with a qualitative approach from March 2016 to October 2017. Participants (36 women with breast cancer) were selected using purposeful sampling and maximum variation from healthcare centers in Alborz province, Iran. The data collection method was a semi-structured interview analyzed by the conventional content-analysis approach defined by Graneheim and Lundman. Results: The current study found that the facilitators in coping with body image altered in women with breast cancer were "supportive resources" extracted from the four subcategories of "receive/understand spouse support," "perceived support by the family," "support by peers in real life or online" and "support by non-governmental organizations. "The barriers to coping with body image altered were "unsympathetic interactions" and "failure of the health system to provide services." Conclusions: According to the findings of the present study, supportive guidelines and planning context-based integrated care are needed to improve facilitators and remove barriers, which allow people to cope better with body image altered.
- 21 October 2022
- Published by Brieflands in Modern Care Journal
- Vol. 20 (1)
Open AccessFacilitating Factors and Barriers to Coping with Body Image Altered in Women with Breast Cancer
Background: Coping with body image alteration is one of the most challenging breast cancer treatments. Identifying the facilitators and barriers is essential for integrative care planning to improve coping with body image in women with breast cancer. Objectives: This study aimed to explore facilitating factors and barriers to coping with body image altered in women with breast cancer. Methods: This study was done with a qualitative approach from March 2016 to October 2017. Participants (36 women with breast cancer) were selected using purposeful sampling and maximum variation from healthcare centers in Alborz province, Iran. The data collection method was a semi-structured interview analyzed by the conventional content-analysis approach defined by Graneheim and Lundman. Results: The current study found that the facilitators in coping with body image altered in women with breast cancer were "supportive resources" extracted from the four subcategories of "receive/understand spouse support," "perceived support by the family," "support by peers in real life or online" and "support by non-governmental organizations. "The barriers to coping with body image altered were "unsympathetic interactions" and "failure of the health system to provide services." Conclusions: According to the findings of the present study, supportive guidelines and planning context-based integrated care are needed to improve facilitators and remove barriers, which allow people to cope better with body image altered.
- Open Access
- 1 January 2021
- Published by Korean Society of Clinical Nutrition in Clinical Nutrition Research
- Vol. 10 (4) , 330-340
Dietary Intake of Polyphenols and the Risk of Breast Cancer: a Case-Control Study
Bahrami A, et al. Clin Nutr Res. 2021 Oct;10(4):330-340. https://doi.org/10.7762/cnr.2021.10.4.330
- 1 January 2021
- Published by Korean Society of Clinical Nutrition in Clinical Nutrition Research
- Vol. 10 (4) , 330-340
Open AccessDietary Intake of Polyphenols and the Risk of Breast Cancer: a Case-Control Study
Bahrami A, et al. Clin Nutr Res. 2021 Oct;10(4):330-340. https://doi.org/10.7762/cnr.2021.10.4.330
- 14 September 2020
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 73 (10) , 1890-1897
Gaussian Graphical Models Identified Food Intake Networks among Iranian Women with and without Breast Cancer: A Case-Control Study
Dietary patterns may be an important predictor of breast cancer risk. However, they cannot completely explain the pairwise correlations among foods. The purpose of this study is to compare food intake networks derived by Gaussian Graphical Models (GGMs) for women with and without breast cancer to better understand how foods are consumed in relation to each other according to disease status. A total of 134 women with breast cancer and 267 hospital controls were selected from referral hospitals of Tehran, Iran. Dietary intakes were evaluated by using a validated 168 food-items semi-quantitative food frequency questionnaire. GGMs were applied to log-transformed intakes of 28 food groups to construct outcome-specific food networks. Among cases, a main network containing intakes of 12 central food groups (vegetables, fruits, nuts and seeds, olive oil and olive, processed meat, sweets, salt, soft drinks, fried potatoes, pickles, low-fat dairy, pizza) was detected. In controls, a main network including six central food groups (liquid oils, vegetables, fruits, sweets, fried potatoes and soft drinks) was identified. The findings of this study revealed a difference in GGM-identified networks graphs between cases and controls. Overall, GGM may provide additional understanding of relationships between diet and health.
- 14 September 2020
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 73 (10) , 1890-1897
Gaussian Graphical Models Identified Food Intake Networks among Iranian Women with and without Breast Cancer: A Case-Control Study
Dietary patterns may be an important predictor of breast cancer risk. However, they cannot completely explain the pairwise correlations among foods. The purpose of this study is to compare food intake networks derived by Gaussian Graphical Models (GGMs) for women with and without breast cancer to better understand how foods are consumed in relation to each other according to disease status. A total of 134 women with breast cancer and 267 hospital controls were selected from referral hospitals of Tehran, Iran. Dietary intakes were evaluated by using a validated 168 food-items semi-quantitative food frequency questionnaire. GGMs were applied to log-transformed intakes of 28 food groups to construct outcome-specific food networks. Among cases, a main network containing intakes of 12 central food groups (vegetables, fruits, nuts and seeds, olive oil and olive, processed meat, sweets, salt, soft drinks, fried potatoes, pickles, low-fat dairy, pizza) was detected. In controls, a main network including six central food groups (liquid oils, vegetables, fruits, sweets, fried potatoes and soft drinks) was identified. The findings of this study revealed a difference in GGM-identified networks graphs between cases and controls. Overall, GGM may provide additional understanding of relationships between diet and health.
- Open Access
- 22 January 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (24) , 10933-10935
Candida non albicans with a High Amphotericin B Resistance Pattern Causing Candidemia among Cancer Patients
Candida non albicans with a High Amphotericin B Resistance Pattern Causing Candidemia among Cancer Patients Candidemia;cancer patients;Candida non albicans;multiplex PCR;amphotericin B resistance; Background: Many scientists have reported Candida species to be of great concern because of the high frequency that they colonize and infect human hosts, particularly cancer patients. Moreover, in the last decades Candida species have developed resistance to many antifungal agents. Based on this, we aimed to identify and determine the prevalence of Candida spp from blood culture bottles among cancer patients and their antifungal resistance pattern. Materials and Methods: From the blood culture bottles isolation and identification of the Candida spp were performed by conventional microbiological techniques. The in vitro antibiotic resistance pattern of the isolates was determined by CLSI guidelines. Genomic DNA was isolated and amplified. Each gene was separated by agar gel electrophoresis. Results: Identification of Candida spp was based on the presence of yeast cells in direct examination, culture and DNA extraction. Of the 68 blood samples collected during the study period (April 2013 to October 2013), five (7.35%) were positive for the presence of Candida spp, 2 (40%) of which were identified as Candida albicans and 3 (60%) were Candida non-albicans. Conclusions: High resistance to amphotricin B was observed among all the Candida non-albicans isolates. Regular investigations into antifungal resistance will help us to get an updated knowledge about their antibiotic resistance pattern which may help the physician in selecting the antibiotics for empirical therapy.
- 22 January 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (24) , 10933-10935
Open AccessCandida non albicans with a High Amphotericin B Resistance Pattern Causing Candidemia among Cancer Patients
Candida non albicans with a High Amphotericin B Resistance Pattern Causing Candidemia among Cancer Patients Candidemia;cancer patients;Candida non albicans;multiplex PCR;amphotericin B resistance; Background: Many scientists have reported Candida species to be of great concern because of the high frequency that they colonize and infect human hosts, particularly cancer patients. Moreover, in the last decades Candida species have developed resistance to many antifungal agents. Based on this, we aimed to identify and determine the prevalence of Candida spp from blood culture bottles among cancer patients and their antifungal resistance pattern. Materials and Methods: From the blood culture bottles isolation and identification of the Candida spp were performed by conventional microbiological techniques. The in vitro antibiotic resistance pattern of the isolates was determined by CLSI guidelines. Genomic DNA was isolated and amplified. Each gene was separated by agar gel electrophoresis. Results: Identification of Candida spp was based on the presence of yeast cells in direct examination, culture and DNA extraction. Of the 68 blood samples collected during the study period (April 2013 to October 2013), five (7.35%) were positive for the presence of Candida spp, 2 (40%) of which were identified as Candida albicans and 3 (60%) were Candida non-albicans. Conclusions: High resistance to amphotricin B was observed among all the Candida non-albicans isolates. Regular investigations into antifungal resistance will help us to get an updated knowledge about their antibiotic resistance pattern which may help the physician in selecting the antibiotics for empirical therapy.
- Open Access
- 10 May 2014
- Published by Maad Rayan Publishing Company in International Journal of Enteric Pathogens
- Vol. 2 (2)
Survey of Enteric Pathogens Causing Bacteremia in Cancer Patients
Survey of Enteric Pathogens Causing Bacteremia in Cancer Patients - International Journal of Enteric Pathogens - - Alborz University of Medical Sciencs, Alborz, IR Iran
- 10 May 2014
- Published by Maad Rayan Publishing Company in International Journal of Enteric Pathogens
- Vol. 2 (2)
Open AccessSurvey of Enteric Pathogens Causing Bacteremia in Cancer Patients
Survey of Enteric Pathogens Causing Bacteremia in Cancer Patients - International Journal of Enteric Pathogens - - Alborz University of Medical Sciencs, Alborz, IR Iran